Login / Signup

Inhibition of the NLRP3 inflammasome prevents ovarian aging.

José M Navarro-PandoElísabet Alcocer-GómezBeatriz Castejón-VegaElena Navarro-VillaránMónica Condés-HervásMaría Mundi-RoldanJordi MuntanéAntonio J Pérez-PulidoPedro BullónChun WangHal M HoffmanAlberto SanzGabriel MbalavieleBernhard RyffelMario D Cordero
Published in: Science advances (2021)
Inflammation is a hallmark of aging and is negatively affecting female fertility. In this study, we evaluate the role of the NLRP3 inflammasome in ovarian aging and female fertility. Age-dependent increased expression of NLRP3 in the ovary was observed in WT mice during reproductive aging. High expression of NLRP3, caspase-1, and IL-1β was also observed in granulosa cells from patients with ovarian insufficiency. Ablation of NLRP3 improved the survival and pregnancy rates and increased anti-Müllerian hormone levels and autophagy rates in ovaries. Deficiency of NLRP3 also reduced serum FSH and estradiol levels. Consistent with these results, pharmacological inhibition of NLRP3 using a direct NLRP3 inhibitor, MCC950, improved fertility in female mice to levels comparable to those of Nlrp3-/- mice. These results suggest that the NLRP3 inflammasome is implicated in the age-dependent loss of female fertility and position this inflammasome as a potential new therapeutic target for the treatment of infertility.
Keyphrases